KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares Outstanding
Ratios

Co-Diagnostics (CODX) Accumulated Depreciation & Amortization (2017 - 2024)

Historic Accumulated Depreciation & Amortization for Co-Diagnostics (CODX) over the last 8 years, with Q4 2024 value amounting to $2.2 million.

  • Co-Diagnostics' Accumulated Depreciation & Amortization rose 4299.64% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year increase of 4299.64%. This contributed to the annual value of $2.2 million for FY2024, which is 4299.64% up from last year.
  • Per Co-Diagnostics' latest filing, its Accumulated Depreciation & Amortization stood at $2.2 million for Q4 2024, which was up 4299.64% from $1.5 million recorded in Q4 2023.
  • Co-Diagnostics' Accumulated Depreciation & Amortization's 5-year high stood at $2.2 million during Q4 2024, with a 5-year trough of $262922.0 in Q4 2020.
  • Over the past 5 years, Co-Diagnostics' median Accumulated Depreciation & Amortization value was $1.0 million (recorded in 2022), while the average stood at $1.1 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 3840.19% in 2020, then skyrocketed by 10675.22% in 2021.
  • Co-Diagnostics' Accumulated Depreciation & Amortization (Quarter) stood at $262922.0 in 2020, then soared by 106.75% to $543597.0 in 2021, then surged by 90.44% to $1.0 million in 2022, then soared by 45.88% to $1.5 million in 2023, then soared by 43.0% to $2.2 million in 2024.
  • Its Accumulated Depreciation & Amortization was $2.2 million in Q4 2024, compared to $1.5 million in Q4 2023 and $1.0 million in Q4 2022.